Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 196,422
  • Shares Outstanding, K 50,755
  • Annual Sales, $ 81,060 K
  • Annual Income, $ -55,550 K
  • EBIT $ -50 M
  • EBITDA $ -48 M
  • 60-Month Beta 2.58
  • Price/Sales 2.32
  • Price/Cash Flow N/A
  • Price/Book 1.96

Options Overview Details

View History
  • Implied Volatility 216.33% ( -10.49%)
  • Historical Volatility 76.65%
  • IV Percentile 95%
  • IV Rank 79.23%
  • IV High 271.40% on 08/14/24
  • IV Low 6.26% on 05/13/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 50
  • Volume Avg (30-Day) 26
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 902
  • Open Int (30-Day) 1,026

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.22
  • Number of Estimates 4
  • High Estimate -0.11
  • Low Estimate -0.31
  • Prior Year -0.22
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.65 +9.32%
on 12/05/24
4.60 -13.26%
on 11/11/24
-0.24 (-5.67%)
since 11/08/24
3-Month
3.65 +9.32%
on 12/05/24
7.03 -43.24%
on 09/17/24
-2.39 (-37.46%)
since 09/09/24
52-Week
2.71 +47.23%
on 12/12/23
8.45 -52.78%
on 07/24/24
+1.12 (+39.02%)
since 12/08/23

Most Recent Stories

More News
Insider Purchase: EVP of $SGHT (SGHT) Buys 3,376 Shares

Manohar K. Raheja, the EVP of $SGHT ($SGHT), bought 3,376 shares of the company on 12-03-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

SGHT : 3.99 (+3.10%)
Insider Purchase: EVP of $SGHT (SGHT) Buys 4,624 Shares

Manohar K. Raheja, the EVP of $SGHT ($SGHT), bought 4,624 shares of the company on 11-29-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings...

SGHT : 3.99 (+3.10%)
Insider Sale: Director at $SGHT (SGHT) Sells 551,802 Shares

Staffan Encrantz, a director at $SGHT ($SGHT), sold 551,802 shares of the company on 11-21-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 46.6% of their...

SGHT : 3.99 (+3.10%)
Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

SGHT : 3.99 (+3.10%)
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

SGHT : 3.99 (+3.10%)
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT : 3.99 (+3.10%)
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT : 3.99 (+3.10%)
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT : 3.99 (+3.10%)
Stock Index Futures Slip as Investors Brace for U.S. Inflation Data, Oracle Results Disappoint

September S&P 500 futures (ESU23) are down -0.23%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.26% this morning as market participants exercised caution and refrained from taking big positions...

ESU23 : 4,491.72s (-0.32%)
NQU23 : 15,435.20s (-0.28%)
TSLA : 389.79 (+0.15%)
QCOM : 160.74 (+0.77%)
TWNK : 33.30 (-0.15%)
RTX : 116.58 (-1.20%)
ORCL : 190.45 (-0.65%)
ABF.LN : 2,216.000 (-0.72%)
SGHT : 3.99 (+3.10%)
SLRN : 4.29 (+0.94%)
GERN : 3.98 (+1.27%)
AER : 95.27 (-0.67%)
3 Prime Healthcare Takeover Targets

These three companies are attractive targets for their potential.

CRSP : 49.84 (-4.76%)
BMRN : 66.81 (+0.10%)
SGHT : 3.99 (+3.10%)
VRTX : 473.98 (+2.57%)

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 4.32
2nd Resistance Point 4.22
1st Resistance Point 4.10
Last Price 3.99
1st Support Level 3.89
2nd Support Level 3.79
3rd Support Level 3.67

See More

52-Week High 8.45
Fibonacci 61.8% 6.26
Fibonacci 50% 5.58
Fibonacci 38.2% 4.90
Last Price 3.99
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar